Probate en es it fr

Probate Brand names, Probate Analogs

Probate Brand Names Mixture

  • No information avaliable

Probate Chemical_Formula

C20H23NS

Probate RX_link

No information avaliable

Probate fda sheet

Probate msds (material safety sheet)

Probate Synthesis Reference

No information avaliable

Probate Molecular Weight

309.469 g/mol

Probate Melting Point

< 25 oC

Probate H2O Solubility

Soluble as HCl salt

Probate State

Liquid

Probate LogP

5.7

Probate Dosage Forms

Tablets (oral, 1 mg)

Probate Indication

Used for the symptomatic treatment of parkinsonism.

Probate Pharmacology

Metixene is a tertiary antimuscarinic with actions similar to those of atropine; it also has antihistaminic and direct antispasmodic properties. It is used for the symptomatic treatment of parkinsonism, including the alleviation of the extrapyramidal syndrome induced by other drugs such as phenothiazines, but, like other antimuscarinics, it is of no value against tardive dyskinesias. Metixene has been discontinued.

Probate Absorption

Absorbed in the gastrointestinal tract following oral administration, however the extent of absorption is not known.

Probate side effects and Toxicity

Signs of overdose include dilated and sluggish pupils, warm, dry skin, facial flushing, decreased secretions of the mouth, pharynx, nose, and bronchi, foul-smelling breath, elevated temperature, tachycardia, cardiac arrhythmias, decreased bowel sounds, urinary retention, delirium, disorientation, anxiety, hallucinations, illusions, confusion, incoherence, agitation, hyperactivity, ataxia, loss of memory, paranoia, combativeness, and seizures.

Probate Patient Information

Probate Organisms Affected

Humans and other mammals